The future of continuous renal replacement therapy.
continuous renal replacement therapy
hemodiafiltration
hemodialysis
hemofiltration
information technology
prescription
Journal
Seminars in dialysis
ISSN: 1525-139X
Titre abrégé: Semin Dial
Pays: United States
ID NLM: 8911629
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
07
01
2021
received:
19
11
2020
accepted:
23
01
2021
pubmed:
21
2
2021
medline:
15
3
2022
entrez:
20
2
2021
Statut:
ppublish
Résumé
Over the last 40 years, acute renal replacement therapy (RRT) in the intensive care units (ICUs) of high-income countries has transitioned from the predominant use of intermittent hemodialysis (and the much less common use of peritoneal dialysis) to the almost exclusive use of continuous renal replacement therapy (CRRT). Accordingly, CRRT has become the most common form of vital organ support delivered to critically ill patients. A series of clinical and technical advances has enabled the transformation of basic CRRT machines into highly sophisticated and customized devices. Recent work has focused on using evidence from clinical trials to enhance the application of CRRT with regard to timing of initiation, choice of modality, dose, and anticoagulation. However, many questions remain unanswered. Uncertainty surrounding volume control and the utility of strategies to minimize circulatory stress are key areas for future development. Advances in membrane technology, combination with other extracorporeal therapies, and personalization of CRRT delivery may provide additional benefit to certain subgroups. Development of quality metrics and use of data analytics to audit and benchmark could provide important insight into practice, while biofeedback and automated CRRT prescription could increase safety. In this review, we summarize the evolution of CRRT and highlight several future areas for development.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
576-585Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Vaamonde CA, Michael UF, Metzger RA, Carroll KE. Complications of acute peritoneal dialysis. J Chronic Dis. 1975;28(11-12):637-659.
Kjellstrand CM, Evans RL, Petersen RJ, Shideman JR, von Hartitzsch B, Buselmeier TJ. The “unphysiology” of dialysis: a major cause of dialysis side effects? Kidney Int Suppl. 1975;2:30-34.
Routh GS, Briggs JD, Mone JG, Ledingham IM. Survial from acute renal failure with and without multiple organ dysfunction. Postgrad Med J. 1980;56(654):244-247.
Kramer P, Schrader J, Bohnsack W, Grieben G, Gröne HJ, Scheler F. Continuous arteriovenous haemofiltration. A new kidney replacement therapy. Proc Eur Dial Transpl Assoc. 1981;18:743-749.
Ronco C, Brendolan A, Bragantini L, et al. Continuous arterio-venous haemofiltration. In: Sieberth H-G, Mann H, eds. Contributions to Nephrology. Basel: Karger; 1985: p. 70-88.
Ronco C, Brendolan A, Bragantini L, et al. Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration. Kidney Int. 1986;29(4):908-915.
Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP. Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics. Ann Intern Med. 1983;99(4):445-460.
Geronemus R, Schneider N. Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure. Trans Am Soc Artif Intern Organs. 1984;30:610-613.
Baldwin IC, Elderkin TD. Continuous hemofiltration: nursing perspectives in critical care. New Horiz. 1995;3(4):738-747.
Macias WL, Mueller BA, Scarim SK, Robinson M, Rudy DW. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis. 1991;18(4):451-458.
Ricci Z, Bonello M, Salvatori G, et al. Continuous renal replacement technology: from adaptive technology and early dedicated machines towards flexible multipurpose machine platforms. Blood Purif. 2004;22(3):269-276.
Ronco C, Garzotto F, Brendolan A, et al. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet. 2014;383(9931):1807-1813.
Bagshaw SM, Wald R, Adhikari NKJ, et al. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240-251.
Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122-133.
Stads S, Kant KM, de Jong MFC, et al. Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study. BMC Nephrol. 2019;20(1):129.
Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA. 2016;315(20):2190-2199.
Ostermann M, Joannidis M, Pani A, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif. 2016;42(3):224-237.
Friedrich JO, Wald R, Bagshaw SM, Burns KEA, Adhikari NKJ. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16(4):R146.
Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627-1638.
Palevsky PM, Zhang JH, O’Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7-20.
Warrillow S, Fisher C, Bellomo R. Correction and control of hyperammonemia in acute liver failure. Crit Care Med. 2020;48(2):218-224.
Ronco C, Brendolan A, D’Intini V, Ricci Z, Lou WM, Bellomo R. Coupled plasma filtration adsorption: rationale, technical development and early clinical experience. Blood Purif. 2003;21(6):409-416.
Reiter K, Bellomo R, Ronco C, Kellum JA. Pro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock? Crit Care. 2002;6(1):18-21.
Borthwick EMJ, Hill CJ, Rabindranath KS, Maxwell AP, McAuley DF, Blackwood B. High-volume haemofiltration for sepsis in adults. Cochrane Database Syst Rev. 2017;1:CD008075.
Bai M, Zhou M, He L, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098-2110.
Szamosfalvi B, Frinak S, Yee J. Sensors and hybrid therapies: a new approach with automated citrate anticoagulation. Blood Purif. 2012;34(2):80-87.
Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol. 2011;6(5):966-973.
Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422-427.
Payen D, de Pont A-CJM, Sakr Y, Spies C, Reinhart K, Vincent J-L. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12(3):R74.
Bellomo R, Cass A, Cole L, et al. An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. Crit Care Med. 2012;40(6):1753-1760.
Steuer RR, Leypoldt JK, Cheung AK, Senekjian HO, Conis JM. Reducing symptoms during hemodialysis by continuously monitoring the hematocrit. Am J Kidney Dis. 1996;27(4):525-532.
Santoro A, Mancini E, Paolini F, Cavicchioli G, Bosetto A, Zucchelli P. Blood Volume Regulation During Hemodialysis. Am J Kidney Dis. 1998;32(5):739-748.
Tonelli M, Astephen P, Andreou P, Beed S, Lundrigan P, Jindal K. Blood volume monitoring in intermittent hemodialysis for acute renal failure. Kidney Int. 2002;62(3):1075-1080.
Ronco C, Brendolan A, Bellomo R. Online monitoring in continuous renal replacement therapies. Kidney Int. 1999;56:S8-14.
Kron S, Leimbach T, Wenkel R, Thieme U, Kern H, Kron J. Relative blood volume monitoring during renal replacement therapy in critically ill patients with septic shock: a preliminary report. Blood Purif. 2015;40(2):133-138.
Buchanan C, Mohammed A, Cox E, et al. Intradialytic cardiac magnetic resonance imaging to assess cardiovascular responses in a short-term trial of hemodiafiltration and hemodialysis. J Am Soc Nephrol. 2017;28(4):1269-1277.
Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914-920.
Findlay MD, Dawson J, Dickie DA, et al. Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients. J Am Soc Nephrol. 2019;30(1):147-158.
Marants R, Qirjazi E, Grant CJ, Lee T-Y, McIntyre CW. Renal perfusion during hemodialysis: intradialytic blood flow decline and effects of dialysate cooling. J Am Soc Nephrol. 2019;30(6):1086-1095.
Naorungroj T, Neto AS, Zwakman-Hessels L, et al. Mediators of the impact of hourly net ultrafiltration rate on mortality in critically ill patients receiving continuous renal replacement therapy. Crit Care Med. 2020;48(10):e934-e942.
Murugan R, Kerti SJ, Chang C-C, et al. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration. JAMA Netw Open. 2019;2(6):e195418.
Bell M, Ronco C, Hansson F, Broman M. Hypothermia during CRRT, a comparative analysis. Acta Anaesthesiol Scand. 2020;64(8):1162-1166.
Combes A, Pesenti A, Ranieri VM. Fifty years of research in ARDS. Is extracorporeal circulation the future of acute respiratory distress syndrome management? Am J Respir Crit Care Med. 2017;195(9):1161-1170.
Terragni P, Del Sorbo L, Mascia L, et al. Tidal volume lower than 6 ml/kg enhances lung protection. Anesthesiology. 2009;111(4):826-835.
Combes A, Fanelli V, Pham T, Ranieri VM. Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. 2019;45(5):592-600.
Cove ME, MacLaren G, Federspiel WJ, Kellum JA. Bench to bedside review: Extracorporeal carbon dioxide removal, past present and future. Crit Care. 2012;16(5):232.
Allardet-Servent J, Castanier M, Signouret T, Soundaravelou R, Lepidi A, Seghboyan J-M. Safety and efficacy of combined extracorporeal CO2 removal and renal replacement therapy in patients with acute respiratory distress syndrome and acute kidney injury. Crit Care Med. 2015;43(12):2570-2581.
Ostermann M, Connor M, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation. Curr Opin Crit Care. 2018;24(6):493-503.
Lee C-C, Chen S-W, Cheng Y-L, et al. The impact of CRRT modality in patients with AKI receiving ECMO: a nationwide registry study in Taiwan. J Crit Care. 2020;57:102-107.
Kes P, Janssens ME, Bašić-Jukić N, Kljak M. A randomized crossover study comparing membrane and centrifugal therapeutic plasma exchange procedures. Transfusion. 2016;56(12):3065-3072.
Ahmed S, Kaplan A. Therapeutic plasma exchange using membrane plasma separation. Clin J Am Soc Nephrol. 2020;15(9):1364-1370.
Schmidt M, Hodgson C, Combes A. Extracorporeal gas exchange for acute respiratory failure in adult patients: a systematic review. Crit Care. 2015;19(1):99.
Ronco C. The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis. Crit Care. 2005;9(6):631-633.
Cruz DN, De Cal M, Piccinni P, Ronco C. Polymyxin-B hemoperfusion and endotoxin removal: Lessons from a review of the literature. Contrib. Nephrol.. 2010;77-82.
Payen D. Haemoperfusion with polymyxin B membrane: recent results for an old debate!. Anaesth Crit Care Pain Med. 2019;38(1):3-4.
Gruda MC, Ruggeberg K-G, O’Sullivan P, et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. Eller K, editor. PLoS One. 2018;13(1):e0191676.
Schädler D, Pausch C, Heise D, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. Eller K, editor. PLoS One. 2017;12(10):e0187015.
Shiga H, Hirasawa H, Nishida O, et al. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report. Blood Purif. 2014;38(3-4):211-218.
Kobashi S, Maruhashi T, Nakamura T, Hatabayashi E, Kon A. The 28-day survival rates of two cytokine-adsorbing hemofilters for continuous renal replacement therapy: a single-center retrospective comparative study. Acute Med Surg. 2019;6(1):60-67.
Shen YI, Wang X-L, Wang B, et al. Survival benefits with artificial liver support system for acute-on-chronic liver failure. Medicine. 2016;95(3):e2506.
Bañares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial. Hepatology. 2013;57(3):1153-1162.
Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67(2):711-720.
Warrillow S, Tibballs H, Bailey M, et al. Characteristics, management and outcomes of patients with acute liver failure admitted to Australasian intensive care units. Crit care Resusc. 2019;21(3):188-199.
Kellum JA, Ronco C. The 17th acute disease quality initiative international consensus conference: introducing precision renal replacement therapy. Blood Purif. 2016;42(3):221-223.
Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision continuous renal replacement therapy and solute control. Blood Purif. 2016;42(3):238-247.
Mottes TA, Goldstein SL, Basu RK. Process based quality improvement using a continuous renal replacement therapy dashboard. BMC Nephrol. 2019;20(1):17.
Kashani K, Herasevich V. Utilities of electronic medical records to improve quality of care for acute kidney injury: past, present. Future. Nephron. 2015;131(2):92-96.
Clark WR, Villa G, Neri M, Ronco C. Advances in machine technology. Contrib Nephrol.. 2018;80-89.